Literature DB >> 2058803

Genetic analyses of the biphasic nature of the alcohol dose-response curve.

B C Dudek1, T J Phillips, M E Hahn.   

Abstract

Ethanol (ETOH)-induced locomotor activation and depression were studied in 23 genotypes of mice. This included a diallel cross of four inbred strains tested with a range of ETOH doses from 0 to 2.75 g/kg. The diversity in shapes of the biphasic ETOH dose-response curves was both qualitative and quantitative, and additive gene action characterized the genetic control of the dose-response curve. Small dominance effects were typically directional in the direction of more activation, or resistance to sedation. No evidence was found for maternal effects, sex linkage, or epistasis. Sex differences were seen in the increased susceptibility of male mice to locomotor sedation at higher ETOH doses. In the diallel cross, there was no correlation between the degree of activation produced by low ETOH doses and sedation produced by higher doses. This indicates that while considerable genetic influences exist for both activational and sedative domains of ETOH effects, these genetic influences are relatively independent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2058803     DOI: 10.1111/j.1530-0277.1991.tb01867.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  24 in total

1.  Ontogeny of the stimulant and sedative effects of ethanol in male and female Swiss mice: gradual changes from weaning to adulthood.

Authors:  Caroline Quoilin; Vincent Didone; Ezio Tirelli; Etienne Quertemont
Journal:  Psychopharmacology (Berl)       Date:  2010-08-04       Impact factor: 4.530

2.  Identification of an acute ethanol response quantitative trait locus on mouse chromosome 2.

Authors:  K Demarest; J McCaughran; E Mahjubi; L Cipp; R Hitzemann
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

3.  Behavioral pharmacogenetic analysis on the role of the α4 GABA(A) receptor subunit in the ethanol-mediated impairment of hippocampus-dependent contextual learning.

Authors:  Jesse D Cushman; Melissa D Moore; Nate S Jacobs; Richard W Olsen; Michael S Fanselow
Journal:  Alcohol Clin Exp Res       Date:  2011-09-21       Impact factor: 3.455

4.  Ethanol sensitization in a neurodevelopmental lesion model of schizophrenia in rats.

Authors:  Susan K Conroy; Zachary Rodd; R Andrew Chambers
Journal:  Pharmacol Biochem Behav       Date:  2006-08-28       Impact factor: 3.533

5.  Locomotor responses to benzodiazepines, barbiturates and ethanol in diazepam-sensitive (DS) and -resistant (DR) mice.

Authors:  T J Phillips; E J Gallaher
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Comparisons of subcolonies of selectively bred long-sleep and short-sleep mice.

Authors:  B C Dudek; D K Yi; D M Gilliam; K T Irtenkauf
Journal:  Behav Genet       Date:  1993-05       Impact factor: 2.805

7.  Glyoxalase 1 (GLO1) Inhibition or Genetic Overexpression Does Not Alter Ethanol's Locomotor Effects: Implications for GLO1 as a Therapeutic Target in Alcohol Use Disorders.

Authors:  Amanda M Barkley-Levenson; Frances A Lagarda; Abraham A Palmer
Journal:  Alcohol Clin Exp Res       Date:  2018-04-18       Impact factor: 3.455

8.  Dopamine antagonist effects on locomotor activity in naive and ethanol-treated FAST and SLOW selected lines of mice.

Authors:  E H Shen; J C Crabbe; T J Phillips
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

9.  The alpha 3 subunit gene of the nicotinic acetylcholine receptor is a candidate gene for ethanol stimulation.

Authors:  H M Kamens; C S McKinnon; N Li; M L Helms; J K Belknap; T J Phillips
Journal:  Genes Brain Behav       Date:  2008-09-30       Impact factor: 3.449

Review 10.  Genetic correlations among ethanol-related behaviors and neurotensin receptors in long sleep (LS) x short sleep (SS) recombinant inbred strains of mice.

Authors:  V G Erwin; B C Jones
Journal:  Behav Genet       Date:  1993-03       Impact factor: 2.805

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.